FDA approves UroGen’s bladder cancer hydrogel after negative adcomm vote

The FDA on Thursday approved UroGen’s application for its bladder cancer drug, despite a negative vote from an advisory committee last month. The drug, which UroGen will brand as Zusduri, is …